Guide
In supplements, finance, and health, the line that would normally carry the ad is usually the line you are not allowed to say. That is not a reason to test less — it is the reason craft has to do all the work, and the reason to screen the compliant cut before you spend.
Be clear about the boundary before anything else. A predicted attention score says nothing about whether your claims are legal, whether your disclosures are adequate, or whether a specific phrase will pass ad review. That is a question for your compliance team, your counsel, and the platform's own review process. Nothing on this page — and nothing a pre-test outputs — is regulatory advice. Get the creative cleared first. Everything below assumes you are testing an ad you are already allowed to run.
In a category with no guardrails, a big promise can drag a mediocre ad across the line — the claim does the stopping and the creative just delivers it. Regulated categories take that shortcut away. You often cannot say the result outright, cannot imply the outcome, cannot show the before-and-after the way a cosmetics or fitness brand might. What is left is everything else: the opening, the pacing, the demonstration, the specificity, the credibility of the person on camera. Those levers were always available — regulation just makes them the only ones. So the same discipline that makes any ad scroll-stopping matters more here, not less.
A common trap: the team builds a punchy cut with the claim in it, loves it, then strips the claim for legal and quietly assumes the softened version performs the same. It often does not. Removing the promise can gut the hook, flatten the payoff, or leave the ad circling a benefit it is no longer allowed to name. The version worth testing is the one that will actually go live. Pre-test the compliant cut on its own merits and find out whether it still holds attention — before you discover in-market that the ad you were allowed to run is the one nobody watched. If it sags, the fix is a stronger hook or a sharper demonstration, not a claim you cannot use.
When you cannot state the outcome, show the mechanism. Demonstrate the product working, walk through how it is made or used, and let specificity carry the credibility a claim used to. Compliant social proof — a real person describing their own experience within the rules — often holds attention better than a sanitized benefit statement anyway; the structure of a testimonial ad is built for exactly this constraint. Screen a few of these approaches against each other. The predicted engagement curve will usually separate the demonstration that earns attention from the disclaimer-heavy cut that quietly loses it after the first line.
Pre-testing predicts attention and engagement from the creative's audio-visual features — it screens whether a compliant ad is watchable, not whether it converts and not whether it is legal. It will not tell you if a mandated disclosure is long enough or if a phrase crosses a line; that stays with your review process. What it will tell you is whether the version you can run holds a viewer the way the version you wanted to run would have. For regulated advertisers that is the exact blind spot — knowing, before spend, whether compliance quietly cost you the attention too. Pair it with the reasons ads underperform in why ads don't convert, and treat the score as the screen that runs before your live test, never instead of it.
Upload your cleared creative and get a predicted engagement read before you spend — up to 8 free credits.
Test Your Ad CreativeOnce your legal and compliance team has cleared what you're allowed to say, the remaining variable is craft: whether the compliant version still holds attention. Pre-testing predicts engagement from the creative's audio-visual features, so you can compare compliant cuts against each other and confirm the one you can legally run is also the one that keeps viewers watching.
No. Pre-testing scores predicted attention and engagement — it does not review claims, disclosures, or regulatory language. Compliance is a legal question that belongs to your counsel or ad-review process. The score tells you whether an already-compliant creative earns attention, not whether the copy is allowed.
Because the shortcut is gone. In an unregulated category a bold claim can carry a weak ad; in supplements, finance, or health, that claim is often off the table, so attention has to be earned through structure, pacing, and demonstration instead. That makes the creative craft the whole game — and worth screening before you spend.